SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
ASCO15: Bristol Myers Cancer Drug Combo Shrinks 60% of Melanomas, As Oncology Roars
Drug Development
ASCO15 EXCLUSIVE: Cancer Drug Could Be Next New Melanoma Med Approved by FDA, Says Genentech Exec
June 1, 2015
 · 
4 min read
ASCO15: Bristol Myers Cancer Drug Combo Shrinks 60% of Melanomas, As Oncology Roars
Drug Development
ASCO15 EXCLUSIVE: Genentech VP Tells BioSpace Gazyva a “Clear Advance” For NHL Treatment
June 1, 2015
 · 
4 min read
Biotech Bay
What Genentech’s New Building Says About Biotech’s Bay Area Economic Impact
May 26, 2015
 · 
1 min read
Job Trends
Genentech Opens New Bay Area Green Building to House Up to 1,500 Workers
May 21, 2015
 · 
3 min read
Business
Three Former Genentech Researchers Launch Neuroscience Company Denali Therapeutics With $217 Million
May 14, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech Lung Cancer Treatments Shrink Tumors, Prolong Life
May 14, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AbbVie, Genentech Leukemia Drug Wins Breakthrough Status Tag
May 7, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Biotech Bay
In Fight Against Alzheimer’s, $100 Million Genentech Trial in Colombia May Be Ground Zero
April 27, 2015
 · 
3 min read
Business
23andMe Steals Another Genentech Vet for Roster
April 2, 2015
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
FDA Grants Genentech’s Cobimetinib Priority Review For Use In Combination With Zelboraf (Vemurafenib) In Advanced Melanoma
February 19, 2015
 · 
7 min read
FDA
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) For Treatment Of Diabetic Retinopathy In People With Diabetic Macular Edema
February 9, 2015
 · 
7 min read
Drug Development
Genentech Shows Off Positive Phase III Lymphoma Data From Late-Stage Study
February 4, 2015
 · 
13 min read
Drug Development
FDA Grants Breakthrough Therapy Designation For Genentech’s Investigational Cancer Immunotherapy MPDL3280A (Anti-PDL1) In Non-Small Cell Lung Cancer
February 2, 2015
 · 
3 min read
Business
Genentech Strikes DNA Sequencing Deal With Genome Pioneer Venter
January 14, 2015
 · 
2 min read
Policy
Genentech Release: FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application With New Data In Previously Untreated Chronic Lymphocytic Leukemia
December 29, 2014
 · 
14 min read
Drug Development
Genentech Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer
December 19, 2014
 · 
11 min read
Policy
Genentech Submits New Drug Application To FDA For Investigational Cobimetinib Used In Combination With Zelboraf (Vemurafenib) In Advanced Melanoma
December 15, 2014
 · 
8 min read
Biotech Bay
Genentech To Present Clinical Data From Six Different Medicines At American Society of Hematology Annual Meeting
December 5, 2014
 · 
13 min read
FDA
FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy To Treat Women With Platinum-Resistant Recurrent Ovarian Cancer
November 17, 2014
 · 
1 min read
Load More